Rchr
J-GLOBAL ID:202201002802107904   Update date: Jun. 16, 2024

Hiranyakorn Methanee

ヒランヤコン メタニー | Hiranyakorn Methanee
Affiliation and department:
Job title: Assistant Professor
Research keywords  (3): Glycoconjugate ,  Protein dynamics ,  Structural Biology
Papers (5):
  • Maho Yagi-Utsumi, Haruko Miura, Christian Ganser, Hiroki Watanabe, Methanee Hiranyakorn, Tadashi Satoh, Takayuki Uchihashi, Koichi Kato, Kei-ichi Okazaki, Kazuhiro Aoki. Molecular Design of FRET Probes Based on Domain Rearrangement of Protein Disulfide Isomerase for Monitoring Intracellular Redox Status. International Journal of Molecular Sciences. 2023. 24. 16. 12865-12865
  • Methanee Hiranyakorn, Shogo Iwamoto, Asako Hoshinoo, Ryo Tsumura, Hiroki Takashima, Masahiro Yasunaga, Shino Manabe. Chromatographic Analysis of N-glycan Profile on Therapeutic Antibodies using FcγRIIIa Affinity Column Chromatography. ACS Omega. 2023. 8. 18. 16513-16518
  • Methanee Hiranyakorn, Maho Yagi-Utsumi, Saeko Yanaka, Naoya Ohtsuka, Norie Momiyama, Tadashi Satoh, Koichi Kato. Mutational and Environmental Effects on the Dynamic Conformational Distributions of Lys48-Linked Ubiquitin Chains. International Journal of Molecular Sciences. 2023. 24. 7. 6075
  • Yagi-Utsumi, M., Ch, ak, M.S., Yanaka, S., Hiranyakorn, M., Nakamura, T., Kato, K., Kuwajima, K. Residual Structure of Unfolded Ubiquitin as Revealed by Hydrogen/Deuterium-Exchange 2D NMR. Biophysical Journal. 2020. 119. 10. 2029-2038
  • Methanee Hiranyakorn, Saeko Yanaka, Tadashi Satoh, Thunchanok Wilasri, Benchawan Jityuti, Maho Yagi-Utsumi, Koichi Kato. NMR Characterization of Conformational Interconversions of Lys48-Linked Ubiquitin Chains. International Journal of Molecular Sciences. 2020. 21. 15. 5351-5351
MISC (2):
  • 高島大輝, HIRANYAKORN Methanee, 岩本将吾, 星野尾麻子, 眞鍋史乃, 眞鍋史乃, 安永正浩. Pharmacokinetic study of glyco-engineered antibodies. 日本糖質学会年会要旨集. 2023. 42nd
  • 眞鍋史乃, 眞鍋史乃, 岩本将吾, 星野尾麻子, 長門石暁, 木下崇司, HIRANYAKORN Methanee, 津本浩平, 津本浩平. Development of Technology for Asymmetric Homogeneous Glycan-Remodeling of Therapeutic IgG. メディシナルケミストリーシンポジウム講演要旨集. 2022. 39th (CD-ROM)
Lectures and oral presentations  (15):
  • Homogeneous asymmetric glycosylated rituximab binding affinity with FcγRIIIa investigated through enzymatic glycan remodeling technology
    (The 2nd annual meeting of the antibody society of Japan 2023)
  • Chemo-enzymatic N-glycan remodeling for homogeneous asymmetric glycosylated IgG and the influence of N-glycosylation on FcγRIIIa binding affinity
    (The 2023 annual meeting of the Society for Glycobiology, Hawaii 2023)
  • Glycoengineering technology for producing homogeneous asymmetric glycosylated IgG and analysis on FcγRIIIa column chromatography
    (The 42nd Annual Meeting of Japanese Society of Carbohydrate Research 2023)
  • Pharmacokinetic study of glyco-engineered antibodies
    (The 42nd Annual Meeting of Japanese Society of Carbohydrate Research 2023)
  • Synthetic study for spiruchostatin A-linked antibody drug conjugate
    (2023)
more...
Education (2):
  • 2016 - 2021 The Graduate University for Advanced Studies (SOKENDAI) Functional Molecular Science
  • 2011 - 2015 Kasetsart University Biochemistry
Professional career (1):
  • Ph.D. (Institute for Molecular Science)
Awards (6):
  • 2023/09 - The Japanese Society of Carbohydrate Research (JSCR) The Japanese Society of Carbohydrate Research (JSCR) travel award/ICS Travel fund award
  • 2023/03 - Promotion and Mutual Aid Corporation for Private Schools of Japan (PMAC) Young female researcher award
  • 2016/10 - Japanese government MEXT scholarship (Monbukagakusho) for doctoral degree 5 years program
  • 2015/04 - Kasetsart University Second class honors of B.Sc.
  • 2015/03 - Kasetsart University Outstanding academic achievement award
Show all
Association Membership(s) (4):
The pharmaceutical society of Japan ,  Japanese Society for Antibody Research ,  Japanese Society of Carbohydrate Research ,  Biophysical Society of Japan
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page